Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$11,065,869
+$1,214,225 QoQ
Shares Held
43,975
-2.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#875
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITY HOLDING CO holds $54,117,792 across 11 Drug Manufacturers - General names. ABBV ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,405 | $28,072,660 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
43,975 | $11,065,869 | |
| 3 | JNJ |
Johnson & Johnson
|
29,051 | $7,378,082 | |
| 4 | AMGN |
Amgen Inc
|
12,282 | $4,447,557 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,085 | $1,424,422 | |
| 6 | PFE |
Pfizer Inc
|
35,409 | $852,648 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
14,061 | $810,194 | |
| 8 | NVS |
Novartis AG
|
190 | $29,776 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,065,869 | 43,975 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $9,851,644 | 45,297 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $10,314,267 | 45,141 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $10,015,031 | 43,254 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $7,888,107 | 42,496 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $8,554,701 | 40,830 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $7,125,236 | 40,097 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $8,019,070 | 40,607 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $6,943,472 | 40,482 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $7,344,821 | 40,334 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $6,182,683 | 39,896 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $5,891,447 | 39,524 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,906,462 | 36,417 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $5,459,378 | 34,256 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $5,217,902 | 32,287 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $4,074,884 | 30,362 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,268,569 | 27,870 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $4,218,750 | 26,024 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $3,572,393 | 26,384 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $3,160,806 | 29,302 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $3,131,166 | 27,798 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $2,757,986 | 25,485 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $2,692,143 | 25,125 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,062,306 | 23,545 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,289,557 | 23,320 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $1,530,352 | 20,086 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||